Acellular Tissue Engineered Vessel

· Vascudyne, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acellular Tissue Engineered Vessel, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass [NA]